Share ownership Anika Therapeutics, Inc.

ANIK

US0352551081

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-13 pm EDT			5-day change	1st Jan Change
14.20 ^USD	-0.70%		+0.57%	+47.76%

Feb. 27	Barrington Adjusts Price Target on Anika Therapeutics to $17 From $16, Maintains Outperform Rating	MT
Feb. 27	B. Riley Adjusts Price Target on Anika Therapeutics to $18 From $16, Maintains Buy Rating	MT

Share class: Anika Therapeutics, Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	15,038,596	14,144,776 ( 94.06 %)	393,000 ( 2.613 %)	94.06 %

Major shareholders: Anika Therapeutics, Inc.

Name	Equities	%	Valuation
BlackRock Advisors LLC 11.17 %	1,610,864	11.17 %	23 M $
Caligan Partners LP 9.952 %	1,435,130	9.952 %	21 M $
Caligan Partners LP 9.952 %	1,435,130	9.952 %	21 M $
Vanguard Fiduciary Trust Co. 5.403 %	779,165	5.403 %	11 M $
Morgan Stanley Capital Services LLC 5.355 %	772,230	5.355 %	11 M $
Acadian Asset Management LLC 4.206 %	606,544	4.206 %	9 M $
Boothbay Fund Management LLC 3.706 %	534,507	3.706 %	8 M $
Renaissance Technologies LLC 3.576 %	515,717	3.576 %	7 M $
The Capital Management Corp. 3.47 %	500,465	3.47 %	7 M $
DFA Australia Ltd. 3.343 %	482,098	3.343 %	7 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	81%
Other	12.63%
Individuals	4.52%
State Street Corp.	2.33%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	87.99%
Individuals	4.52%
Australia	3.34%
United Kingdom	3.26%
Canada	0.6%
Hong Kong	0.29%
Cayman Islands	0.15%
France	0.11%
Luxembourg	0.09%
Ireland	0.08%
Finland	0.04%
Netherlands	0.01%

Based on 1000 largest holdings

Anika Therapeutics, Inc. is a global joint preservation company. The Company creates and delivers advancements in early intervention orthopedic care, including in the areas of osteoarthritis (OA) pain management, regenerative solutions, and sports medicine. It is focused on developing, manufacturing and commercializing products on its hyaluronic acid (HA), technology platform. Its OA Pain Management product family consists of Monovisc and Orthovisc, its injectable, HA, OA Pain Management offerings are indicated to provide pain relief from osteoarthritis conditions; and Cingal, its novel, next generation, single-injection OA Pain Management product consisting of its proprietary cross-linked HA material combined with a steroid. Its Joint Preservation and Restoration product family consists of its portfolio of orthopedic regenerative solutions products utilizing HA, including Integrity, its new hyaluronic acid-based scaffold for rotator cuff and other tendon repairs.

Employees

235

Sector

Medical Equipment, Supplies & Distribution

More about the company